International, randomized controlled trial of lamifiban (a glycoprotein IIB/IIIA inhibitor), heparin, or both in unstable angina

There is no fulltext present in this item.

Title:	International, randomized controlled trial of lamifiban (a glycoprotein IIB/IIIA inhibitor), heparin, or both in unstable angina
Author(s):	Moliterno, D.J.; Werf, F. van de; Diaz, R.; Paoloasso, E.; Aylward, P.; Simes, J.; Col, J.; Pegas, L.; Armstrong, P.W.; Langer, A.; Grande, P.; Bono, D. de; Heikkilä, J.; Vahanian, A.; Neuhaus, K.; Rutsch, W.; Toutouzas, P.; Kristinsson, P.; Tzivoni, D.; Ardessino, D.; White, H.; Seabra-Gomes, R.; Betriu, A.; Dalby, A.; Emanuelsson, H.; Pfisterer, M.; Verheugt, F.W.A. ; e.a., .
Publication year:	1998
Source:	Circulation, vol. 97, (1998), pp. 2386-2395
ISSN:	0009-7322
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/188794
Display more details
Subject:	Reperfusion therapy in acute coronary syndromes Reperfusietherapie bij acute coronaire syndromen
Organization:	Cardiology
Journal title:	Circulation
Volume:	vol. 97
Page start:	p. 2386
Page end:	p. 2395